(Total Views: 555)
Posted On: 05/25/2020 8:20:58 PM
Post# of 86957
Cannabis and anxiety
Cannabis has powerful anxiolytic (anti-anxiety) properties, and when administered as-needed, can provide relief from several anxiety disorders.
Anxiety, like marijuana, comes with a stigma, but with the increasing impact of anxiety disorders on family life and the economy, it’s no wonder everyone seems to be looking for a salve.
The relationship between cannabis and anxiety disorders exists, but remains wholly misunderstood. Anxiety presents differently in every patient, and there is no definitive cure with conventional drugs, so just imagine something as variant as the cannabis plant.
Evidence suggests that cannabis has powerful anxiolytic (anti-anxiety) properties, and when administered as-needed, can provide relief from several anxiety disorders, including generalized and social anxiety, obsessive-compulsive disorder, social anxiety, post-traumatic stress disorder, panic disorder, and depression. It might even help with a fear of public speaking.
Source: Benzinga newsletter
Cannabis has powerful anxiolytic (anti-anxiety) properties, and when administered as-needed, can provide relief from several anxiety disorders.
Anxiety, like marijuana, comes with a stigma, but with the increasing impact of anxiety disorders on family life and the economy, it’s no wonder everyone seems to be looking for a salve.
The relationship between cannabis and anxiety disorders exists, but remains wholly misunderstood. Anxiety presents differently in every patient, and there is no definitive cure with conventional drugs, so just imagine something as variant as the cannabis plant.
Evidence suggests that cannabis has powerful anxiolytic (anti-anxiety) properties, and when administered as-needed, can provide relief from several anxiety disorders, including generalized and social anxiety, obsessive-compulsive disorder, social anxiety, post-traumatic stress disorder, panic disorder, and depression. It might even help with a fear of public speaking.
Source: Benzinga newsletter
(7)
(0)
